AB Science says a newly identified blood biomarker may help assess masitinib activity in its ongoing Phase 3 ALS clinical ...
Early birds are at a significantly lower risk of developing amyotrophic lateral sclerosis (ALS) than night owls, according to a new study.
Rather than worrying about bucket list adventures, columnist Juliet Taylor and her late husband, Jeff, focused on friends and ...
Columnist Kristin Neva finds herself unable to sleep one night as she mulls over her husband's ALS disease progression.
QRL-201 shows potential to slow ALS progression by restoring a key protein needed for nerve health, according to data from a Phase 1/2 trial.
The MDA Shamrocks campaign returns nationwide, raising funds for neuromuscular research and families living with ALS and other rare diseases.
Columnist Dagmar Munn once kept busy with multitasking, but living with ALS has taught her the value of slowing down.
A UNLV scientist was named the winner of the inaugural MDA Research Momentum Award for his work investigating the underlying causes of ALS.
Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that results in the death of nerve cells called motor neurons in the brain and spinal cord. These neurons control voluntary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results